Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial

Journal of Rheumatology

Volumn 27, Issue 9, 2000, Pages 2222-2226

  McKenzie, R ^a   Reynolds, J C ^a   O'Fallon, A ^a   Dale, J ^a   Deloria, M ^a   Blackwelder, W ^a   Straus, S E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Absorptiometry; Bone density; Glucocorticoids; Osteoporosis

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; PLACEBO; PREDNISONE;

AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; OSTEOPOROSIS; SPINE;

EID: 0033812397     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. The basophil adenomas of the pituitary body and their clinical manifestations
2. Vertebral fractures resulting from prolonged cortisone and corticotropin therapy
3. The systemic side effects of steroid therapy
4. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases
5. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: A longitudinal study
6. The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: A cross-sectional and a longitudinal study using single photon absorptiometry
7. Bone mineral content in patients with rheumatoid arthritis; relationship to low-dose steroid therapy
8. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis
9. Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids
10. Glucocorticoid-induced osteoporosis: Pathogenesis prevention and treatment, with special regard to the rheumatic diseases
11. Glucocorticoid-induced osteoporosis: Pathogenesis and management
12. Effects of prednisone and deflazacort on vertebral bone mass
13. Bone loss in response to long-term glucocorticoid therapy
14. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis, a randomized, controlled study
15. Comparison of the effects of auranofin, gold sodium thiomalate, and penicillamine on resorption of cultured fetal rat long bones
16. Increased metacarpal bone mass following 18 months of slow-acting antirheumatic drugs for rheumatoid arthritis
17. Quantitative CT for determination of bone mineral density: A review
18. Low-dose hydrocortisone for treatment of chronic fatigue syndrome; a randomized controlled trial
19. Chronic fatigue syndrome: A working case definition
20. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial
21. A scale for measuring depression
22. Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss
23. A comparison of lateral versus anterior-posterior spine dual energy x-ray absorptiometry for the diagnosis of osteopenia
24. Dual X-ray absorptiometry of the lumbar spine: The precision of paired anteroposterior/lateral studies
25. Bone mineral density in women with depression
26. Bone loss in adults receiving alternate day glucocorticoid therapy: A comparison with daily therapy
27. Corticosteroid-induced bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography
28. Inhaled corticosteroids - Effect on bone?
29. Effect of inhaled corticosteroids on bone
30. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
31. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
32. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
33. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss
34. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
35. Reversibility of steroid-induced osteoporosis